BR0013719A - Dosagem oral de liberaçâo controlada, apropriada para administração oral - Google Patents
Dosagem oral de liberaçâo controlada, apropriada para administração oralInfo
- Publication number
- BR0013719A BR0013719A BR0013719-7A BR0013719A BR0013719A BR 0013719 A BR0013719 A BR 0013719A BR 0013719 A BR0013719 A BR 0013719A BR 0013719 A BR0013719 A BR 0013719A
- Authority
- BR
- Brazil
- Prior art keywords
- controlled
- oral administration
- oral
- release
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Abstract
"DOSAGEM ORAL DE LIBERAçãO CONTROLADA, APROPRIADA PARA ADMINISTRAçãO ORAL". A presente invenção se refere a uma composição farmacêutica, preferivelmente na forma de um comprimido compreendendo uma quantidade terapeuticamente eficaz de um medicamento em um veículo compreendendo um polímero insolúvel em água e um sal inorgânico, insolúvel em água.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15211499P | 1999-09-02 | 1999-09-02 | |
PCT/US2000/040781 WO2001015665A1 (en) | 1999-09-02 | 2000-08-30 | Controlled release oral dosage suitable for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0013719A true BR0013719A (pt) | 2002-07-23 |
Family
ID=22541568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0013719-7A BR0013719A (pt) | 1999-09-02 | 2000-08-30 | Dosagem oral de liberaçâo controlada, apropriada para administração oral |
Country Status (8)
Country | Link |
---|---|
US (1) | US6437000B1 (pt) |
EP (1) | EP1207852A4 (pt) |
JP (1) | JP2003508420A (pt) |
AU (1) | AU783656B2 (pt) |
BR (1) | BR0013719A (pt) |
CA (1) | CA2383212C (pt) |
NZ (1) | NZ517466A (pt) |
WO (1) | WO2001015665A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020187192A1 (en) * | 2001-04-30 | 2002-12-12 | Yatindra Joshi | Pharmaceutical composition which reduces or eliminates drug abuse potential |
CN100379408C (zh) * | 2003-07-28 | 2008-04-09 | 马林克罗特公司 | 改进的硬脂酸盐组合物及制备方法 |
EP1680110B1 (en) * | 2003-11-04 | 2011-01-05 | Supernus Pharmaceuticals, Inc. | Once daily dosage forms of trospium |
AU2004289221B2 (en) * | 2003-11-04 | 2009-12-17 | Supernus Pharmaceuticals, Inc | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
US8709476B2 (en) | 2003-11-04 | 2014-04-29 | Supernus Pharmaceuticals, Inc. | Compositions of quaternary ammonium compounds containing bioavailability enhancers |
PL2402005T3 (pl) | 2005-08-24 | 2021-11-22 | Endo Pharmaceuticals Inc. | Formulacje nalbufiny o przedłużonym uwalnianiu |
US8394812B2 (en) | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
FR2894143B1 (fr) * | 2005-12-01 | 2008-05-02 | Pierre Fabre Medicament Sa | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. |
KR101661246B1 (ko) * | 2006-02-10 | 2016-09-29 | 마나테크, 인코포레이티드 | 흡수 및 생물학적 이용 증진을 위한 완전 천연 종합 비타민 및 종합 미네랄 건강 보조제 |
US7731604B2 (en) * | 2006-10-31 | 2010-06-08 | Taylor Made Golf Company, Inc. | Golf club iron head |
NZ577814A (en) | 2006-11-27 | 2012-03-30 | Lundbeck & Co As H | Imidazo[1,2-a]pyridine amide derivatives |
CN107080734B (zh) | 2008-03-20 | 2020-10-30 | 维尔恩公司 | 包含生育酚的peg衍生物的乳剂 |
EP2268274B1 (en) * | 2008-03-20 | 2012-05-16 | Virun, Inc. | Vitamin e derivatives and their uses |
BRPI0917206B1 (pt) * | 2008-07-31 | 2018-04-17 | Clarke Mosquito Control Products, Inc. | Método para a formação de uma pastilha comprimida de liberação dupla, pastilhas comprimidas e método para a fabricação de uma matriz sólida de liberação prolongada |
CA2792330C (en) * | 2010-03-23 | 2017-01-03 | Virun, Inc | Nanoemulsion including a peg-derivative of vitamin e and a sucrose fatty acid ester |
KR102408805B1 (ko) * | 2016-10-17 | 2022-06-14 | 리드스 에이비 | 고유의 특성을 지닌 황산칼슘 반수화물을 생산하는 새로운 방법 |
EP3345591A1 (en) | 2017-01-06 | 2018-07-11 | Oystershell NV | Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation |
WO2018127594A1 (en) | 2017-01-06 | 2018-07-12 | Oystershell Nv | Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3488418A (en) | 1965-11-18 | 1970-01-06 | Sterling Drug Inc | Sustained relief analgesic composition |
US3584114A (en) | 1968-05-22 | 1971-06-08 | Hoffmann La Roche | Free-flowing powders |
US3773920A (en) | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
US4025613A (en) | 1971-07-19 | 1977-05-24 | Richard G. Powers | Timed-release aspirin |
BE787973A (fr) * | 1971-09-04 | 1973-02-26 | Beecham Group Ltd | Comprimes pharmaceutiques a effet retard |
US4218433A (en) | 1977-03-03 | 1980-08-19 | Nippon Kayaku Kabushiki Kaisha | Constant-rate eluting tablet and method of producing same |
US4361545A (en) | 1979-05-21 | 1982-11-30 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion |
US4415547A (en) | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
HU187215B (en) | 1983-01-26 | 1985-11-28 | Egyt Gyogyszervegyeszeti Gyar | Method for producing pharmaceutical product of high actor content and prolonged effect |
US4539198A (en) | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
US4690824A (en) | 1983-07-07 | 1987-09-01 | Redi-Rowell, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
JPS6124516A (ja) | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
DE3431861A1 (de) | 1984-08-30 | 1986-03-13 | Troponwerke GmbH & Co KG, 5000 Köln | Pellet-zubereitung |
DE3438291A1 (de) * | 1984-10-19 | 1986-04-24 | Röhm GmbH, 6100 Darmstadt | Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln |
GB8507779D0 (en) | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
IE63321B1 (en) | 1986-02-03 | 1995-04-05 | Elan Corp Plc | Drug delivery system |
GB2186485B (en) | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
JPS62223112A (ja) | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
US4832957A (en) | 1987-12-11 | 1989-05-23 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
GB2196252B (en) | 1986-09-18 | 1990-10-17 | London Pharmacy Innovation | Gastric controlled-release dosage forms |
US4760094A (en) | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4767789A (en) | 1986-10-21 | 1988-08-30 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4990335A (en) | 1987-03-25 | 1991-02-05 | E. I. Du Pont De Nemours And Company | Use of vinyl alcohol homopolymer and copolymers for tableting active materials |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5271946A (en) | 1988-04-20 | 1993-12-21 | Asta Pharma Aktiengesellschaft | Controlled release azelastine-containing pharmaceutical compositions |
US5009897A (en) | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
JP2514078B2 (ja) | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
US5002774A (en) | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
US4983399A (en) | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
JP2572673B2 (ja) | 1990-07-25 | 1997-01-16 | エスエス製薬株式会社 | 徐放性錠剤 |
CA2061520C (en) | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
CA2141788C (en) * | 1992-08-04 | 2001-12-11 | James M. Dunn | Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
ZA936723B (en) * | 1992-09-14 | 1995-08-14 | Vesta Med Pty Ltd | Pharmaceutical preparations for lowering homocysteine levels |
TW272942B (pt) | 1993-02-10 | 1996-03-21 | Takeda Pharm Industry Co Ltd | |
SI9520049A (en) * | 1994-05-06 | 1997-12-31 | Pfizer | Controlled-release dosage forms of azithromycin |
WO1997017951A1 (en) * | 1995-11-14 | 1997-05-22 | Knoll Pharmaceutical Company | Stabilized thyroid hormone preparations and methods of making same |
US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
-
2000
- 2000-08-30 JP JP2001519879A patent/JP2003508420A/ja active Pending
- 2000-08-30 BR BR0013719-7A patent/BR0013719A/pt not_active Application Discontinuation
- 2000-08-30 CA CA002383212A patent/CA2383212C/en not_active Expired - Fee Related
- 2000-08-30 AU AU11059/01A patent/AU783656B2/en not_active Ceased
- 2000-08-30 NZ NZ517466A patent/NZ517466A/en unknown
- 2000-08-30 EP EP00972391A patent/EP1207852A4/en not_active Withdrawn
- 2000-08-30 US US09/650,837 patent/US6437000B1/en not_active Expired - Lifetime
- 2000-08-30 WO PCT/US2000/040781 patent/WO2001015665A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2001015665A1 (en) | 2001-03-08 |
CA2383212C (en) | 2008-11-25 |
NZ517466A (en) | 2003-11-28 |
EP1207852A4 (en) | 2009-11-11 |
JP2003508420A (ja) | 2003-03-04 |
EP1207852A1 (en) | 2002-05-29 |
CA2383212A1 (en) | 2001-03-08 |
US6437000B1 (en) | 2002-08-20 |
AU1105901A (en) | 2001-03-26 |
AU783656B2 (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
DE60032749D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
CO5190672A1 (es) | Composicion para la dosificacion oral, de disolucion instantanea | |
BR9812001A (pt) | Composição farmacêutica para combinação de descongestionante piperidinoalcanol | |
MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
IL139229A0 (en) | Drug delivery system comprising a tightly compacted solid medicament stock | |
BR122012014331A8 (pt) | Formulações farmacêuticas | |
BR0015284A (pt) | Formulações de hidrocodona de liberação controlada | |
ATE213629T1 (de) | Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe | |
PT785775E (pt) | Formulacoes opioides extrudidas por fusao administraveis oralmente | |
BR0014383A (pt) | Composições de liberação controlada compreendendo nimesulida | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
BR9917012A (pt) | Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral | |
WO2006072940A3 (en) | Controlled long acting release pharmaceutical preparation for use in the oral cavity | |
HUP0004966A3 (en) | Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
BRPI0412364A (pt) | composição farmacêutica sólida, compreendendo amisulpride | |
AR022621A1 (es) | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina | |
BR0108958A (pt) | Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina | |
BR0014440A (pt) | Formulações de liberação controlada oral | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
DE69803670D1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
BR0012822A (pt) | Formulação farmacêutica, e, forma de dosagem em tablete |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 9/00 Ipc: A61K 9/22 (2009.01) |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |